During the recent session, Acurx Pharmaceuticals Inc (NASDAQ:ACXP)’s traded shares were 0.56 million, with the beta value of the company hitting -1.64. At the last check today, the stock’s price was $0.46, reflecting an intraday loss of -29.29% or -$0.19. The 52-week high for the ACXP share is $3.33, that puts it down -623.91 from that peak though still a striking -30.43% loss since the share price plummeted to a 52-week low of $0.60. The company’s market capitalization is $9.01M, and the average trade volume was 340.77K shares over the past three months.
Acurx Pharmaceuticals Inc (NASDAQ:ACXP) trade information
Acurx Pharmaceuticals Inc (ACXP) registered a -29.29% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -29.29% in intraday trading to $0.46, hitting a weekly high. The stock’s 5-day price performance is -35.02%, and it has moved by -42.25% in 30 days. Based on these gigs, the overall price performance for the year is -84.58%.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -17.77%. While earnings are projected to return 26.96% in 2025, the next five years will return -17.17% per annum.
ACXP Dividends
Acurx Pharmaceuticals Inc is due to release its next quarterly earnings in April. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Acurx Pharmaceuticals Inc (NASDAQ:ACXP)’s Major holders
The next largest institutional holding, with 0.28 million shares, is of PROSPECT FINANCIAL SERVICES LLC’s that is approximately 1.7574% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $0.63 million.
Also, the Mutual Funds coming in first place with the largest holdings of Acurx Pharmaceuticals Inc (ACXP) shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. Data provided on Sep 30, 2024 indicates that Vanguard Total Stock Market Index Fund owns about 383.81 shares. This amounts to just over 1.97 percent of the company’s overall shares, with a $0.18 million market value. The same data shows that the other fund manager holds slightly less at 145.54, or about 0.75% of the stock, which is worth about $69144.0.